Tuesday’s Market Movers: Jobs Data, Homebuilders, IPO Buzz, and a Healthcare Hot Streak

​The Jobs Number Everyone Treats Like a Fire Alarm
Tuesday’s biggest early catalyst is a key government jobs report dropping at 8:30 a.m. ET — the kind of release that can flip futures in seconds. Traders care because labor data can quickly reshape the interest-rate narrative: too hot and rate-cut hopes cool off; too soft and recession whispers get louder.

Lennar Steps Up as Housing Takes a Confidence Test
Homebuilder Lennar reports Tuesday afternoon, and the setup isn’t exactly cozy. The stock is down about 10.5% over the last three months and roughly 20.5% below its 52-week high from last December. The broader homebuilder space has been sliding too, with the SPDR S&P Homebuilders ETF (XHB) down nearly 7% over three months and about 11% off its September peak. Peers are mixed: Hovnanian has dropped about 27.9% in three months, while Toll Brothers has been about flat. Translation: Lennar’s report is a read on whether housing is stabilizing—or still sinking.

The IPO Watch: Medline Could Be the Big One
Investors are also watching for pricing details from Medline, the medical supply company backed by heavyweight names. If it prices at the top end of its expected range, it could become 2025’s biggest IPO. Meanwhile, the Renaissance IPO ETF is up about 5% this year, though it’s still about 16% below its September high. Within that ETF, some names have been on absolute heaters this year — Nextpower up nearly 140% and Tempus AI up about 103% — while Viking Holdings is up around 61% year to date. Over the past month, Chime Financial has been the standout, up about 30%.

Healthcare Is Quietly Winning the Last Three Months
While the market’s been obsessed with AI drama and Fed tea leaves, healthcare has been steadily collecting wins. The S&P healthcare sector rose about 1.3% Monday and sits about 1.8% below its late-November high. More importantly, it’s the top-performing S&P sector over the past three months, up about 14%. Leading the charge: Eli Lilly, up roughly 42% in three months, with Cardinal Health up 33% and Regeneron up 31% over the same stretch.

Bottom Line: Tuesday’s Theme Is “Proof Time”
​Between a market-moving jobs print, a key homebuilder earnings report, a potentially blockbuster IPO pricing, and healthcare’s quiet surge, Tuesday is stacked with signals about where money is flowing — and where investors might be getting nervous.